#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma Skin angiosarcoma Penile squamous cell carcinoma White matter lesion Crohn's disease Stargardt's disease ABO haemolytic disease of newborn Ovarian cancer stage III PIK3CA related overgrowth spectrum Congenital hypotransferrinaemia Haemophilia Waldenstrom's macroglobulinaemia Encephalitis autoimmune Polycythaemia vera Dermatitis More trials…

    Learn about Rare Diseases

    Hyperoxaluria – Trials in Disease Breast angiosarcoma metastatic – Life with Disease Haemophilia A with anti factor VIII – Basic Information Propionic acidaemia Aicardi-Goutieres syndrome – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Lymphatic malformation Carcinoid syndrome – Treatment Haemophagocytic lymphohistiocytosis – Diagnostics Focal segmental glomerulosclerosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Istaroxime Bexotegrast Abiraterone LIPASE Dimeticone Deferoxamine Cetirizine Dihydrochloride Mometasone Icatibant Cldn6 Rna-Lpx Alnuctamab Dexmedetomidine Hydrochloride Oxybutynin Vismodegib Livmoniplimab Eteplirsen A3907 Ataluren Fusidic Acid Domperidone More therapies…

    Learn about Your Condition

    Type V hyperlipidaemia Breast cancer female Liposarcoma recurrent Primary hyperoxaluria Mitochondrial myopathy Clinically isolated syndrome Meniere's disease Corneal graft rejection Coeliac disease Dengue fever Langerhans' cell histiocytosis Obesity Endometrial cancer Thyroid cancer metastatic Niemann-Pick disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on the Safety of Migalastat for Patients with Fabry Disease and Severe Kidney Problems on Dialysis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Migalastat
    France Portugal Spain

  • Study on Insulin Glargine for Patients with Type 2 Diabetes: Comparing Decentralized, Hybrid, and Standard Clinical Trial Approaches

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Insulin-requiring type 2 diabetes mellitus
    Investigated Drugs:
    • Insulin Glargine
    Denmark Germany Italy Poland Spain

  • Study on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis

    Not recruiting

    2 1
    Investigated Drugs:
    • Azd4831
    Denmark Italy Norway Portugal Spain Sweden

  • Study on Ertugliflozin for Children and Teens with Type 2 Diabetes

    Not recruiting

    3 1
    Investigated Drugs:
    • Ertugliflozin
    Hungary Italy Poland

  • Study on Octreotide for Nutritional Recovery After Surgery in Esophageal or Gastric Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal carcinoma
    Investigated Drugs:
    • Octreotide
    Sweden

  • Study on Colchicine for Reducing Inflammation in Patients with Type 1 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Colchicine
    Denmark
Previous Page
1 … 54 55 56 57 58 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!